Overview

A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndrome.
Phase:
Phase 2
Details
Lead Sponsor:
Kissei Pharmaceutical Co., Ltd.
Treatments:
Ophthalmic Solutions